Aprecia & Purdue collaboration focuses on 3D printed pharmaceuticals
Purdue University’s College of Pharmacy and Aprecia Pharmaceuticals, LLC announced a partnership focusing on the future of 3D printed pharmaceutical equipment and medications which will foster access to 3D printing resources for faculty and students.
This partnership will also see the university and pharmaceutical company embarking on joint collaborations in various areas including research, discovery, learning and teaching, engagement, and also technical assistance.
Commenting on this partnership, CEO of Aprecia Chris Gilmore said that the company’s goal is to develop the potential of its 3D printing technology through global partnerships. The company hopes that these collaborations will lead to the discovery of solutions to address unmet patient needs and provide them with better healthcare options.
Gilmore also expressed the company’s confidence in this partnership. “Purdue University is an esteemed institution, and we are confident that this partnership will advance our future in 3D printing pharmaceutical research and development,” he added.
Dean of Purdue’s College of Pharmacy, Eric Barker said that the agreement catalyses the exchange of faculty and research scholar. This partnership will open access for highly educated students, and provide opportunities for joint collaborations.
Barker said that the university is committed to its investment in drug discovery and development as well as student and faculty enrichment that will continue to yield global advancement in medicine and health care.
“As a college, our mission is to prepare the next generation of leaders in pharmacy. Partnering with Aprecia aligns perfectly with that mission.
We are excited to combine our talented students and faculty with the successful researchers at Aprecia to work together to accelerate discoveries in this emerging field,” he said.
The college’s head of the department of industrial and physical pharmacy, Eric Munson said that this collaboration will enable the further development of more advanced medical technology.
Munson believes that this can be achieved by combining the latest technological developments, such as this into the programmes offered at the university.
He stated that the universities view this as the key to producing the best workforce in pharmaceutical formulation and manufacturing.
Benefits of 3D printing for pharmaceuticals
Aprecia has been at the forefront of 3D printed pharmaceuticals since manufacturing the first 3D printed FDA-approved tablet several years ago.
According to an article published in The Pharmaceutical Journal, 3D printing in medicine will enable manufacturers to create specific dosages for each patient. This would be particularly helpful for children since they often require lower dosages of medicines.
As patients differ in terms of need, they often require a modified version of the medication, and 3D printing will allow manufacturers to fulfill this need, at a relatively low cost.